![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Migraine Treatment Device Wins Marketing Clearance
Migraine Treatment Device Wins Marketing Clearance
September 12, 2017
Devicemaker eNeura received 510(k) clearance from the FDA for the eNeura Spring TMS for treatment of migraine headache.
The prescription-only device uses single-pulse transcranial magnetic stimulation to induce a mild electric current that modulates nerve cells in the brain. Patients push a button to deliver a magnetic pulse to treat a migraine attack and or to prevent the onset of future migraine attacks.
SpringTMS has CE Marking in Europe for the acute treatment of migraine and migraine prevention.
Upcoming Events
-
21Oct